About GramEye
GramEye is a company based in Osaka (Japan) founded in 2020.. GramEye has raised $9.67 million across 4 funding rounds from investors including Samurai Incubate, Études and SMBC Venture Capital. GramEye operates in a competitive market with competitors including Smart4Diagnostics, Avicena Systems, Biophos, Milab Online and BeaconLBS, among others.
- Headquarter Osaka, Japan
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$9.67 M (USD)
in 4 rounds
-
Latest Funding Round
$3.64 M (USD), Series B
Nov 24, 2025
-
Investors
Samurai Incubate
& 7 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of GramEye
GramEye has successfully raised a total of $9.67M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $3.64 million completed in November 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $3.6M
- First Round First Round
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2025 | Amount | Series B - GramEye | Valuation | Beyond Next Ventures | |
| Jul, 2024 | Amount | Series B - GramEye | Valuation | Beyond Next Ventures |
|
| Oct, 2023 | Amount | Series A - GramEye | Valuation | Senshu Ikeda Capital , SMBC Venture Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in GramEye
GramEye has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Samurai Incubate, Études and SMBC Venture Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Études is recognized for innovative architectural solutions and services.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Entrepreneurs are supported through funding and guidance by NES.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by GramEye
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - GramEye
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Grameye Comparisons
Competitors of GramEye
GramEye operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Smart4Diagnostics, Avicena Systems, Biophos, Milab Online and BeaconLBS, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Blood sample measurement devices are manufactured for real-time diagnostics.
|
|
| domain | founded_year | HQ Location |
Developer of biosecurity platform and hardware for pathogen testing
|
|
| domain | founded_year | HQ Location |
Offers tools and solutions for automating fertility analysis processes.
|
|
| domain | founded_year | HQ Location |
Online platform for requesting and viewing veterinary laboratory test results.
|
|
| domain | founded_year | HQ Location |
Delivers comprehensive point-of-care laboratory solutions for healthcare professionals.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Grameye
Frequently Asked Questions about GramEye
When was GramEye founded?
GramEye was founded in 2020 and raised its 1st funding round 3 years after it was founded.
Where is GramEye located?
GramEye is headquartered in Osaka, Japan. It is registered at Osaka, Osaka Prefecture, Japan.
Who is the current CEO of GramEye?
Yu Hiraoka is the current CEO of GramEye.
Is GramEye a funded company?
GramEye is a funded company, having raised a total of $9.67M across 4 funding rounds to date. The company's 1st funding round was a Series A of $2.41M, raised on Sep 20, 2023.
What does GramEye do?
GramEye was founded in 2020 in Osaka, Japan, focusing on AI and robotics within the healthcare sector. Solutions are provided to assist outpatient clinics in estimating bacterial species from samples. Disease detection is enabled through this technology, helping to avoid prescriptions of unnecessary medications that contribute to drug-resistant bacteria. Operations center on pathological testing advancements for clinical use.
Who are the top competitors of GramEye?
GramEye's top competitors include Smart4Diagnostics, Avicena Systems and Biophos.
Who are GramEye's investors?
GramEye has 8 investors. Key investors include Samurai Incubate, Études, SMBC Venture Capital, NES Venture Capital, and DEEPCORE.